Chembio Diagnostics, Inc.

NasdaqCM:CEMI Stock Report

Market Cap: US$16.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Chembio Diagnostics Dividend

Dividend criteria checks 0/6

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$0.63
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Chembio gets $3.2M contract from CDC to develop rapid test for syphilis

Sep 06

Chembio stock rises 13% amid plans to develop rapid test for monkeypox

Aug 16

Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?

Nov 30
Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?

Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher

Aug 08
Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher

Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?

Jul 22
Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?

Chembio Diagnostics EPS beats by $0.10, beats on revenue

May 06

Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?

Apr 07
Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?

Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?

Jan 16
Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?

Chembio stock gains after COVID-19 tests nab European Union nod

Jan 14

Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?

Dec 12
Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?

Chembio slumps 13% on delay of U.S. nod for coronavirus antibody test

Dec 04

Chembio nabs BARDA contract for rapid respiratory antigen panel test

Dec 02

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CEMI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CEMI's dividend payments have been increasing.


Dividend Yield vs Market

Chembio Diagnostics Dividend Yield vs Market
How does CEMI dividend yield compare to the market?
SegmentDividend Yield
Company (CEMI)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Medical Equipment)1.7%
Analyst forecast in 3 Years (CEMI)n/a

Notable Dividend: Unable to evaluate CEMI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CEMI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CEMI has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.